Brief: Cannara Biotech Receives Amendment Of Its Licence From Health Canada
02/09/2021 13:28
Sept 2 (Reuters) - Cannara Biotech Inc LOVE.V :
* CANNARA BIOTECH INC. RECEIVES AMENDMENT OF ITS LICENCE
FROM
HEALTH CANADA PERMITTING THE SALE OF CANNABIS 2.0 PRODUCTS AND
PREPARES FOR THE LAUNCH OF ITS HASH PRODUCT LINE IN QUEBEC
Source text for Eikon: ID:nCNWVH9V2a
Further company coverage: LOVE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cannara Biotech
See all newsCanada Research Roundup: Cannara Biotech ,Equinox Gold , Winpak
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4
Cannabis firm Cannara Biotech's Q4 revenue rises on market expansion
Brief: Cannara Biotech Q4 EPS CAD 0.04